{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:31:57Z","timestamp":1783121517755,"version":"3.54.6"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.xphs.2023.11.031","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:00:38Z","timestamp":1701432038000},"page":"772-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development and In-Vitro Evaluation of Eugenol-Based Nanostructured Lipid Carriers for Effectual Topical Treatment Against C. albicans"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3895-8577","authenticated-orcid":false,"given":"Sudarshan Naidu","family":"Chilamakuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9114-0791","authenticated-orcid":false,"given":"Ankaj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Gowri","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhagar","family":"Selvaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sargun","family":"Basrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-8125","authenticated-orcid":false,"given":"Arvind","family":"Gulbake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.11.031_bib0001","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: the silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microb Cell"},{"key":"10.1016\/j.xphs.2023.11.031_bib0002","doi-asserted-by":"crossref","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.xphs.2023.11.031_bib0003","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/jcm.27.6.1335-1341.1989","article-title":"Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome","volume":"27","author":"Brawner","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0004","first-page":"133","article-title":"Antifungals","author":"Campoy Garc\u00eda","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/204237","article-title":"Candida Infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents","author":"Spampinato","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.xphs.2023.11.031_bib0006","article-title":"Development and evaluation of nanocrystals loaded hydrogel for topical application","volume":"74","author":"Kumar","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0007","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.3c01571","article-title":"Natural oils enhance the topical delivery of ketoconazole by nanoemulgel for fungal infections","volume":"8","author":"Ahmad","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.xphs.2023.11.031_bib0008","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/molecules26020461","article-title":"Antifungal activity of Melaleuca alternifolia essential oil (TTO) and its synergy with itraconazole or ketoconazole against Trichophyton rubrum","volume":"26","author":"Roana","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2023.11.031_bib0009","article-title":"In vitro antidermatophytic activity of Otacanthus azureus (Linden) Ronse essential oil alone and in combination with azoles","volume":"116","author":"Houel","year":"2013","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0010","article-title":"Mechanistic evaluations of ketoconazole lipidic nanoparticles for improved efficacy, enhanced topical penetration, cellular uptake (L929 and J774A.1), and safety assessment: in vitro and in vivo studies","volume":"65","author":"Ramzan","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.909851","article-title":"In vitro, ex vivo, and in vivo evaluation of nanoparticle-based topical formulation against Candida albicans infection","volume":"13","author":"Sadozai","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0012","first-page":"47","article-title":"Enhanced antifungal activity of Ketoconazole using rose oil based novel microemulsion formulation","author":"Tiwari","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0013","first-page":"121","article-title":"Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?","author":"Bona","year":"2016","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0014","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.carbpol.2013.02.031","article-title":"Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study","volume":"95","author":"fakhreddin","year":"2013","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2023.11.031_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-021-00523-9","article-title":"High anticancer efficacy of solid lipid nanoparticles containing Zataria multiflora essential oil against breast cancer and melanoma cell lines","volume":"22","author":"Valizadeh","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0016","first-page":"66","article-title":"Solid Lipid Nanoparticles (SLN) carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity","author":"Fazly Bazzaz","year":"2018","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0017","first-page":"16","article-title":"Essential oils as active ingredients of lipid nanocarriers for chemotherapeutic use","author":"Severino","year":"2015","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0018","series-title":"Nanomaterial-Based Drug Delivery Systems: Therapeutic and Theranostic Applications","first-page":"65","article-title":"Lipid-based nanomaterials: a brief note on composition, development, and drug delivery applications","author":"Kumar","year":"2023"},{"key":"10.1016\/j.xphs.2023.11.031_bib0019","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/pharmaceutics11050231","article-title":"Clotrimazole-loaded Mediterranean essential oils NLC: a synergic treatment of candida skin infections","volume":"11","author":"Carbone","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2023.11.031_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/IJN.S152529","article-title":"Essential oil-loaded lipid nanoparticles for wound healing","volume":"13","author":"Saporito","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2023.11.031_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.713616","article-title":"Nanostructured lipid carrier\u2013mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases","volume":"12","author":"Garg","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113325","article-title":"Analytical method development and validation of Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) method for simultaneous quantifications of quercetin and piperine in dual-drug loaded nanostructured lipid carriers","volume":"186","author":"Chaudhari","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2023.11.031_bib0023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/scipharm89020025","article-title":"Olanzapine loaded nanostructured lipid carriers via high shear homogenization and ultrasonication","volume":"89","author":"Ajiboye","year":"2021","journal-title":"Sci Pharm"},{"key":"10.1016\/j.xphs.2023.11.031_bib0024","article-title":"Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: toxicological effect of surface charge on human neuronal cells","volume":"607","author":"Pina Costa","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.11.031_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/02652048.2010.529948","article-title":"Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility","volume":"28","author":"Potta","year":"2011","journal-title":"J Microencapsul"},{"key":"10.1016\/j.xphs.2023.11.031_bib0026","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","article-title":"Nanostructured lipid carriers for site-specific drug delivery","volume":"103","author":"Khosa","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.xphs.2023.11.031_bib0027","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.chemphyslip.2012.01.006","article-title":"characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis","volume":"165","author":"Gupta","year":"2012","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.xphs.2023.11.031_bib0028","article-title":"Ketoconazole-loaded cationic nanoemulsion: in vitro \u2013 ex vivo \u2013 in vivo evaluations to control cutaneous fungal infections","volume":"7","author":"Shahid","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.xphs.2023.11.031_bib0029","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molliq.2017.07.002","article-title":"Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: optimization, in vitro characterization and stability assessment","volume":"242","author":"Verma","year":"2017","journal-title":"J Mol Liq"},{"key":"10.1016\/j.xphs.2023.11.031_bib0030","article-title":"The synthesis and characterization of double nanoemulsion for targeted Co-Delivery of 5-fluorouracil and curcumin using pH-sensitive agarose\/chitosan nanocarrier","volume":"70","author":"Pourmadadi","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0031","article-title":"Development and optimization of nanoemulsion containing exemestane using box-behnken design","volume":"80","author":"Chaturvedi","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"43","key":"10.1016\/j.xphs.2023.11.031_bib0032","doi-asserted-by":"crossref","first-page":"25889","DOI":"10.1039\/D0RA00297F","article-title":"Fluconazole conjugated-gold nanorods as an antifungal nanomedicine with low cytotoxicity against human dermal fibroblasts","volume":"10","author":"Hamad","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2023.11.031_bib0033","article-title":"Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes","volume":"101","author":"Na","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1016\/j.xphs.2023.11.031_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2020.101003","article-title":"Ketoconazole-loaded poly-(lactic acid) nanoparticles: characterization and improvement of antifungal efficacy in vitro against Candida and dermatophytes","volume":"30","author":"Endo","year":"2020","journal-title":"J Mycol Med"},{"key":"10.1016\/j.xphs.2023.11.031_bib0035","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.2147\/IJN.S145695","article-title":"Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model","volume":"12","author":"Tian","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2023.11.031_bib0036","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/adt.2015.29007.ghkdrrr","article-title":"Antiepileptic drugs inhibit growth, dimorphism, and biofilm mode of growth in human pathogen Candida albicans","volume":"13","author":"Kathwate","year":"2015","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0037","article-title":"Sanguinarine, isolated from Macleya cordata, exhibits potent efficacy against Candida albicans through inhibiting the ergosterol synthesis","volume":"13","author":"Hu","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0038","first-page":"39","article-title":"Mechanism of Candida pathogenesis: revisiting the vital drivers","author":"Elibe","year":"2020","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0039","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.3389\/fmicb.2021.741493","article-title":"Antibiofilm activities of biogenic silver nanoparticles against Candida albicans","volume":"12","author":"Ahamad","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.05.016","article-title":"Aripiprazole repurposed as an inhibitor of biofilm formation, and sterol biosynthesis in multi-drug resistant Candida albicans","volume":"54","author":"Rajasekharan","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.xphs.2023.11.031_bib0041","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02652040500162436","article-title":"SLN and NLC for topical delivery of ketoconazole","volume":"22","author":"Souto","year":"2005","journal-title":"J Microencapsul"},{"key":"10.1016\/j.xphs.2023.11.031_bib0042","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1590\/S1517-83822011000400004","article-title":"Evaluation of antifungal activity in essential oil of the Syzygium aromaticum (L.) by extraction, purification and analysis of its main component eugenol","volume":"42","author":"Singh","year":"2011","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.xphs.2023.11.031_bib0043","doi-asserted-by":"crossref","first-page":"143","DOI":"10.22159\/ajpcr.2018.v11i5.23540","article-title":"Optimization and evaluation of topical ketoconazole nanoemulsion","volume":"11","author":"Ernoviya","year":"2018","journal-title":"Asian J Pharmaceut Clin Res"},{"key":"10.1016\/j.xphs.2023.11.031_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.104953","article-title":"Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections","volume":"232","author":"Dudhipala","year":"2020","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.xphs.2023.11.031_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120444","article-title":"Design and characterization of nanostructured lipid carriers (NLC) and nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil","volume":"600","author":"Krambeck","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.11.031_bib0046","article-title":"Enhancement of bioavailability and pharmacodynamic effects of thymoquinone via nanostructured lipid carrier (NLC) formulation","volume":"17","author":"Elmowafy","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2023.11.031_bib0047","first-page":"1231","article-title":"Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies","volume":"9","author":"Gomes","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2023.11.031_bib0048","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0168-3659(00)00367-9","article-title":"Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation","volume":"70","author":"Redhead","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2023.11.031_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10610278.2019.1702663","article-title":"Mechanism for efficient separation of eugenol and eugenol acetate with \u03b2 -cyclodextrin as a selective solvent","volume":"31","author":"Yang","year":"2019","journal-title":"Supramol Chem"},{"key":"10.1016\/j.xphs.2023.11.031_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02652048.2016.1200150","article-title":"Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer","volume":"33","author":"Tupal","year":"2016","journal-title":"J Microencapsul"},{"key":"10.1016\/j.xphs.2023.11.031_bib0051","first-page":"454","article-title":"Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization","author":"Shete","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.11.031_bib0052","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.colsurfb.2011.05.030","article-title":"Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers","volume":"87","author":"Garg","year":"2011","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.xphs.2023.11.031_bib0053","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biopha.2017.02.008","article-title":"Improved yeast delivery of fluconazole with a nanostructured lipid carrier system","volume":"89","author":"Kelidari","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.031_bib0054","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/10717544.2022.2058651","article-title":"In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach","volume":"29","author":"Agrawal","year":"2022","journal-title":"Drug Deliv"},{"issue":"5","key":"10.1016\/j.xphs.2023.11.031_bib0055","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s13346-021-00986-7","article-title":"Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations","volume":"12","author":"Mahmood","year":"2022","journal-title":"Drug Deliv Transl Res"},{"issue":"7","key":"10.1016\/j.xphs.2023.11.031_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12070599","article-title":"Double optimization of rivastigmine-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery using the quality by design (QbD) approach: formulation variables and instrumental parameters","volume":"12","author":"Cunha","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2023.11.031_bib0057","doi-asserted-by":"crossref","DOI":"10.1007\/s13233-012-0107-1","article-title":"Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent","volume":"20","author":"Ramasamy","year":"2012","journal-title":"Macromol Res"},{"key":"10.1016\/j.xphs.2023.11.031_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/gels8050277","article-title":"Hydrogel containing solid lipid nanoparticles loaded with argan oil and simvastatin: preparation, in vitro and ex vivo assessment","author":"Khan","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.xphs.2023.11.031_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237407","article-title":"Anticancer properties of eugenol: a review","author":"Zari","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2023.11.031_bib0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.foodchem.2011.01.055","article-title":"Antioxidant effect of essential oils of rosemary, clove and cinnamon on hazelnut and poppy oils","volume":"129","author":"\u00d6zcan","year":"2011","journal-title":"Food Chem"},{"key":"10.1016\/j.xphs.2023.11.031_bib0061","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopha.2017.01.033","article-title":"Enhanced effect in combination of curcumin- and ketoconazole-loaded methoxy poly (ethylene glycol)-poly (\u03b5-caprolactone) micelles","volume":"88","author":"Teng","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.031_bib0062","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-019-0857-7","article-title":"Antifungal activity of silver nanoparticles in combination with ketoconazole against Malassezia furfur","volume":"9","author":"Mussin","year":"2019","journal-title":"AMB Expr"},{"key":"10.1016\/j.xphs.2023.11.031_bib0063","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.colsurfb.2013.05.041","article-title":"Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity","volume":"111C","author":"Mendes","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.xphs.2023.11.031_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2020.00730","article-title":"Alkylimidazolium ionic liquids as antifungal alternatives: antibiofilm activity against Candida albicans and underlying mechanism of action","volume":"11","author":"Reddy","year":"2020","journal-title":"Front Microbiol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:45:39Z","timestamp":1758361539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923005063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0022354923005063"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.11.031","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and In-Vitro Evaluation of Eugenol-Based Nanostructured Lipid Carriers for Effectual Topical Treatment Against C. albicans","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}